Cases & Deals

  • Home
  • Practices
  • Nanotechnology company exclusively licenses patents in exchange for royalties and equity

Share

Nanotechnology company exclusively licenses patents in exchange for royalties and equity

July 2007

Clients Nanotechnology company

Jones Day represented a holder of patents for nanostructures in negotiating an exclusive field-of-use license to a start up company engaged in research and development of veterinary, medical, therapeutic products and processes employing nanostructures. Consideration for the license consisted of cash, royalties and common stock of the licensee.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.